Legagneur C - Search Results

1

Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real-life experience from a national reference network.

Mosbah H, Vantyghem MC, Nobécourt E, Andreelli F, Archambeaud F, Bismuth E, Briet C, Cartigny M, Chevalier B, Donadille B, Daguenel A, Fichet M, Gautier JF, Janmaat S, Jéru I, Legagneur C, Leguier L, Maitre J, Mongeois E, Poitou C, Renard E, Reznik Y, Spiteri A, Travert F, Vergès B, Zammouri J, Vigouroux C, Vatier C. Mosbah H, et al. Among authors: legagneur c. Diabetes Obes Metab. 2022 Aug;24(8):1565-1577. doi: 10.1111/dom.14726. Epub 2022 May 12. Diabetes Obes Metab. 2022. PMID: 35445532 Free PMC article.

2

High incidence of skin reactions secondary to the use of adhesives in glucose sensors or insulin pumps for the treatment of children with type 1 diabetes.

Genève P, Adam T, Delawoevre A, Jellimann S, Legagneur C, DiPatrizio M, Renard E. Genève P, et al. Among authors: legagneur c. Diabetes Res Clin Pract. 2023 Oct;204:110922. doi: 10.1016/j.diabres.2023.110922. Epub 2023 Sep 26. Diabetes Res Clin Pract. 2023. PMID: 37769906

3

Maternal opioid addiction: A potential cause of elevated 17-OH progesterone in neonatal screening.

Francois-Bic S, Legagneur C, Hubert C, Guéant-Rodriguez RM, Leheup B, Albuisson E, Renard E. Francois-Bic S, et al. Among authors: legagneur c. Arch Pediatr. 2023 Feb;30(2):77-82. doi: 10.1016/j.arcped.2022.11.012. Epub 2022 Dec 14. Arch Pediatr. 2023. PMID: 36526499

4

Additional autoimmune diseases associated with type 1 diabetes in children and adolescents: A French single-center study from 2014 to 2021.

Burbaud M, Renard E, Jellimann S, Luc A, Di Patrizio M, Remen T, Legagneur C. Burbaud M, et al. Among authors: legagneur c. Arch Pediatr. 2022 Jul;29(5):381-387. doi: 10.1016/j.arcped.2022.03.002. Epub 2022 May 27. Arch Pediatr. 2022. PMID: 35637045

5

Congenital hypothyroidism in children with eutopic gland or thyroid hemiagenesis: prognostic factors for transient vs. permanent hypothyroidism.

Bontemps SH, Legagneur C, Guéant-Rodriguez RM, Remen T, Luc A, Renard E. Bontemps SH, et al. Among authors: legagneur c. J Pediatr Endocrinol Metab. 2023 Feb 20;36(4):353-363. doi: 10.1515/jpem-2022-0101. Print 2023 Apr 25. J Pediatr Endocrinol Metab. 2023. PMID: 36798001

6

[Screening for familial hypercholesterolemia from low-density lipoprotein cholesterol levels at admission in the coronary care unit].

Chemaly P, Nallet O, Delarche N, Legagneur C, Boulestreau R, Reibel I, Palette C, Grenier A, Courtade H, Beaune G, Belle L, Georges JL. Chemaly P, et al. Among authors: legagneur c. Ann Cardiol Angeiol (Paris). 2018 Nov;67(5):300-309. doi: 10.1016/j.ancard.2018.08.011. Epub 2018 Oct 2. Ann Cardiol Angeiol (Paris). 2018. PMID: 30290906 French.

7

Identification of factors associated with the management of childhood obesity: Results from a French pediatric cohort study.

Thevenard-Berger A, Patrizio MD, Legagneur C, Wiedemann-Fode A, Renard E. Thevenard-Berger A, et al. Among authors: legagneur c. Arch Pediatr. 2024 Jan;31(1):20-25. doi: 10.1016/j.arcped.2023.09.013. Epub 2023 Nov 21. Arch Pediatr. 2024. PMID: 37989662

8

Atypical phenotype of a patient with Bardet-Biedl syndrome type 4.

Sloboda N, Lambert L, Ciorna V, Bruel AL, Tran Mau-Them F, Gomola V, Lemelle JL, Klein O, Camoin-Schweitzer MC, Magnavacca M, Legagneur C, Ezsto ML, Bonnet C, Philippe C, Leheup B. Sloboda N, et al. Among authors: legagneur c. Mol Genet Genomic Med. 2022 May;10(5):e1869. doi: 10.1002/mgg3.1869. Epub 2022 Mar 23. Mol Genet Genomic Med. 2022. PMID: 35318824 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page